Gaush Meditech Ltd (FRA:F7Y)

Market Cap	93.25M -34.5%
Revenue (ttm)	168.08M -3.4%
Net Income	11.71M +4.1%
EPS	0.08 +5.6%
Shares Out	n/a
PE Ratio	7.96
Forward PE	n/a
Dividend	0.03 (5.67%)
Ex-Dividend Date	Jun 23, 2025

Volume	n/a
Average Volume	50
Open	0.5850
Previous Close	0.6800
Day's Range	0.5850 - 0.5850
52-Week Range	0.5600 - 1.1200
Beta	n/a
RSI	42.01
Earnings Date	Mar 26, 2026

About Gaush Meditech

Gaush Meditech Ltd. engages in the research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company’s product portfolio comprising proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for diagnosis, treatment, or surgeries, being vitreoretinal diseases, cataracts, re...

• Industry: Medical, Dental, and Hospital Equipment and Supplies
• Founded: 1998
• Employees: 819
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: F7Y

Financial Performance

In 2025, Gaush Meditech's revenue was 1.38 billion, a decrease of -3.36% compared to the previous year's 1.43 billion. Earnings were 96.19 million, an increase of 4.11%.

Financial numbers in CNY